%D8%A3%D8%B1%D8%AA%D9%8A%D8%B3%D9%88%D9%86%D8%A7%D8%AA%D8%A7%D8%B1%D8%AA%D8%B3%D9%88%D9%86%D8%A7%D8%AACategory:ArtesunateArtesunatArtesunateArtesunatoArtesunaattiArt%C3%A9sunate%E3%82%A2%E3%83%AB%E3%83%86%E3%82%B9%E3%83%8D%E3%82%A4%E3%83%88%E0%AC%86%E0%AC%B0%E0%AD%8D%E0%AC%9F%E0%AD%87%E0%AC%B8%E0%AD%81%E0%AC%A8%E0%AD%87%E0%AC%9FArtezunatArtesunatoArtesunatArtesunatArtesunatArtesunateQ707939%E9%9D%92%E8%92%BF%E7%90%A5%E9%85%AF
about
P1855
P. Knowlesi Trial of Artesunate-mefloquine Versus ChloroquineAntimalarial Treatments for Clearing Low Density P. Falciparum and Its Impact on Malaria TransmissionArtemisinin Resistance in BangladeshClinical Investigation of In-vivo Susceptibility of P.Falciparum to Artesunate in Western CambodiaArtesunate Plus Sulfadoxine-Pyrimethamine Versus Chloroquine for Vivax MalariaMulti-Centre Trial Comparing Three Artemisinin-Based Combination Treatments on P. Falciparum MalariaACT MALI: Treatment of Malaria Based on Combination TherapiesEfficacy of Amodiaquine-artesunate in Children Aged 6-59 Months With Uncomplicated P. Falciparum MalariaPyronaridine Artesunate (3:1) Versus Coartem® in P Falciparum Malaria PatientsArsucam® (Artesunate + Amiodaquine) Efficacy and TOLeranceEvaluation of Potential Effect of Artemether - Lumefantrine and Malaria Drugs on Auditory FunctionRandomized Trial on Effectiveness of ACTs in GhanaEfficacy and Safety of Dihydroartemisinin/Piperaquine (Artekin®) for the Treatment of Uncomplicated Malaria in PeruChlorproguanil-Dapsone-Artesunate (CDA) Versus Chlorproguanil-Dapsone (LAPDAP) For Uncomplicated MalariaStudy on the Treatment of Vivax MalariaAdherence to Antimalarial Drugs in Sierra LeoneComparing Praziquantel Versus Artesunate + Sulfamethoxypyrazine/Pyrimethamine for Treating SchistosomiasisMass-Drug Administration to Reduce Malaria TransmissionEfficacy and Safety of Artesunate + Amodiaquine With SLD of Primaquine for Treatment of Falciparum Malaria in ZanzibarEfficacy of Artesunate + Amodiaquine Versus Artemether-lumefantrine for Falciparum Malaria in Zanzibar, 2005Tolerability and Efficacy of Artemether-Lumefantrine Versus Artesunate + Amodiaquine in ZanzibarIntermittent Preventive Treatment With Antimalarials in Kenyan InfantsPharmacokinetic Study of Primaquine and Pyronaridine-Artesunate in Healthy SubjectsDrug Interaction Study of Pyronaridine-artesunate and Metoprolol and Pyronaridine-artesunate Re-dosing Study in Healthy VolunteersTracking Resistance to Artemisinin (TRAC)Efficacy of Artemether-lumefantrine, Artesunate-amodiaquine and Dihydroartemisinin-piperaquine for the Treatment of Uncomplicated Plasmodium Falciparum Malaria in MalawiPlasmodium Falciparum Clearance Rates in Response to Artesunate in Eastern CambodiaEfficacy,Safety and Tolerability of Dihydroartemisinin-Piperaquine for Uncomplicated Malaria in Pregnancy in GhanaCommunity Access to Rectal Artesunate for MalariaEfficacy and Safety of ASAQ and PD for the Treatment of Uncomplicated Falciparum Malaria in Mainland TanzaniaIntra-Anally Administered Artesunate in Patients With High-Grade Anal Intraepithelial Neoplasia (AIN 2/3)Artesunate Ointment for the Treatment of High Grade Vulvar Intraepithelial Neoplasia (HSIL VIN2/3)Evaluation of Artesunate-mefloquine as a Novel Alternative Treatment for Schistosomiasis in African ChildrenPyramax in Asymptomatic Carriers of P. Falciparum MonoinfectionsDrug Combinations of Atovaquone-Proguanil (AP) With ACTStudy of the Safety of Intravenous Artesunate (2006-02-14)A Randomised Efficacy Study of Combination Antimalarials to Treat Uncomplicated Malaria (2003-01-31)Effect of Artemisinin-based Combination Therapies on Schistosomiasis on Malaria Co-infectionIn Vivo Efficacy of Artemether-lumefantrine and Amodiaquine-artesunate in Mozambican Children (MEFI_III)Safety and Efficacy of Pyronaridine Artesunate Versus Chloroquine in Children and Adult Patients With Acute Plasmodium Vivax Malaria
P4844
A collaborative epidemiological investigation into the criminal fake artesunate trade in South East AsiaArtesunate versus quinine for treating severe malariaDeclining artesunate-mefloquine efficacy against falciparum malaria on the Cambodia-Thailand borderTreatment outcome of intravenous artesunate in patients with severe malaria in the Netherlands and Belgium.Review of the clinical pharmacokinetics of artesunate and its active metabolite dihydroartemisinin following intravenous, intramuscular, oral or rectal administrationThe initial pharmaceutical development of an artesunate/amodiaquine oral formulation for the treatment of malaria: a public-private partnershipRandomized, multicentre assessment of the efficacy and safety of ASAQ--a fixed-dose artesunate-amodiaquine combination therapy in the treatment of uncomplicated Plasmodium falciparum malariaChanges in the treatment responses to artesunate-mefloquine on the northwestern border of Thailand during 13 years of continuous deploymentChlorproguanil-dapsone-artesunate versus artemether-lumefantrine: a randomized, double-blind phase III trial in African children and adolescents with uncomplicated Plasmodium falciparum malariaNew Fixed-Dose Artesunate-Mefloquine Formulation against Multidrug-Resistant Plasmodium falciparum in Adults: a Comparative Phase IIb Safety and Pharmacokinetic Study with Standard-Dose Nonfixed Artesunate plus MefloquineA Randomised, Double Blind, Placebo-Controlled Pilot Study of Oral Artesunate Therapy for Colorectal CancerSupergenomic network compression and the discovery of EXP1 as a glutathione transferase inhibited by artesunateGametocyte clearance dynamics following oral artesunate treatment of uncomplicated falciparum malaria in Malian childrenPre-referral rectal artesunate for severe malariaArtesunate plus pyronaridine for treating uncomplicated Plasmodium falciparum malariaPre-referral rectal artesunate for severe malariaArtesunate versus quinine for treating severe malariaArtesunate versus quinine for treating severe malariaArtesunate versus quinine for treating severe malariaSulfadoxine-pyrimethamine plus artesunate versus sulfadoxine-pyrimethamine plus amodiaquine for treating uncomplicated malariaArtesunate plus mefloquine versus mefloquine for treating uncomplicated malariaSulfadoxine-pyrimethamine plus artesunate versus sulfadoxine-pyrimethamine plus amodiaquine for treating uncomplicated malariaArtesunate-mefloquine for treating uncomplicated malariaTransmission-blocking activities of quinine, primaquine, and artesunateRepeated treatment of recurrent uncomplicated Plasmodium falciparum malaria in Senegal with fixed-dose artesunate plus amodiaquine versus fixed-dose artemether plus lumefantrine: a randomized, open-label trialArtesunate versus quinine in the treatment of severe falciparum malaria in African children (AQUAMAT): an open-label, randomised trialA qualitative study to identify community structures for management of severe malaria: a basis for introducing rectal artesunate in the under five years children in Nakonde District of ZambiaPharmacokinetics of artesunate after single oral administration to ratsArtesunate plus sulfadoxine-pyrimethamine for treatment of uncomplicated Plasmodium falciparum malaria in Sudan.A randomized trial of artemether-lumefantrine versus mefloquine-artesunate for the treatment of uncomplicated multi-drug resistant Plasmodium falciparum on the western border of Thailand.Post-artesunate delayed haemolysis ‒ report of four cases and review of the literatureDeclining efficacy of artesunate plus sulphadoxine-pyrimethamine in northeastern IndiaTreatment of uncomplicated malaria with artesunate plus sulfadoxine-pyrimethamine is failing in Somalia: evidence from therapeutic efficacy studies and Pfdhfr and Pfdhps mutant allelesClinical trials of artesunate plus sulfadoxine-pyrimethamine for Plasmodium falciparum malaria in Afghanistan: maintained efficacy a decade after introductionHigh efficacy of artemether-lumefantrine and declining efficacy of artesunate + sulfadoxine-pyrimethamine against Plasmodium falciparum in Sudan (2010-2015): evidence from in vivo and molecular marker studiesSustained efficacy of artesunate-sulfadoxine-pyrimethamine against Plasmodium falciparum in Yemen and a renewed call for an adjunct single dose primaquine to clear gametocytesBehavioral and neural toxicity of the artemisinin antimalarial, arteether, but not artesunate and artelinate, in ratsAuthentication of artemether, artesunate and dihydroartemisinin antimalarial tablets using a simple colorimetric methodRecognition, perceptions and treatment practices for severe malaria in rural Tanzania: implications for accessing rectal artesunate as a pre-referralCommunity coverage of an antimalarial combination of artesunate and amodiaquine in Makamba Province, Burundi, nine months after its introduction
P921
Q61713095-A1A283B5-4597-4EEF-948A-F50C138CD48DQ61914369-22E9FF93-C9C0-4A54-A0C2-CCAF518BE43DQ61914985-14CD424B-9BB7-4FA9-95AE-28330065A840Q61917808-6C51C88A-287A-4A48-9F61-04ECFDBFA2FAQ61918402-1AF46263-13D1-44FD-92B8-BE48408B6308Q61918559-006CC7CB-C094-4CE5-AA35-966664FD8740Q61920835-8BE86C76-F151-40C1-B81C-D12991394C36Q61921487-CB58B902-8CCC-49EE-96E3-465185F15C74Q61921811-2D8D9EE5-6D46-46D0-9EE9-611A5786ECA6Q61924518-07F8E27F-BE40-4216-8750-E42952C80CD4Q61924784-7EB8F34D-9F55-4CB2-A244-040B87F37BDCQ61932617-9E9429F9-05E6-473A-AB45-F37CA7102B6DQ61932743-0A4F122B-1BBC-4893-A4BE-7D24B3A86F8AQ61933103-E3747810-7F1D-49AA-8C11-60362FAED190Q61938296-523E490E-92C1-48A9-A70E-F3854675C5FEQ61975589-51E3E203-4CCB-4526-B379-B2280B40FB5BQ61979278-4EC09636-E4D7-4D37-9A43-1BBFA117F646Q61979503-2403ACDC-E4C4-4992-9F37-C9781935B4ACQ62031092-28DA818F-A57D-4048-A39A-9F1AAC1D79BEQ62031515-461A0B13-C926-4585-96FE-EE254D379AC0Q62031869-66E320BC-4211-47F8-AE6E-67489E9A837BQ62105182-6E82C12A-5F81-4AA7-9A0E-7BAAA0B7D4B7Q63319579-6CAFAF54-02CC-4214-8F9B-DBCAC4158B34Q63319693-1D988F87-4412-442D-86A0-AA221AB883A1Q63334695-CB917EB7-55C5-4706-96A1-BC418230BD77Q63338889-03FAC2ED-C39F-45FA-97E8-C87993A3BFFCQ63340289-C9CDDB49-7467-43D2-AFFD-2C19D11FEE94Q63341110-E643AFD5-1D81-488B-B569-C8E24C34DFFEQ63397795-C3F4EF12-C9E3-4972-BE5B-A10B5E04C497Q63403905-172BC36D-167B-4D90-B2F2-96B09CA9C207Q63576512-E6BE7F31-F4B1-4CAD-ACBA-592D108B9FDAQ63578782-26421F8D-A5BD-40C5-A07A-9976C4E5245CQ63579989-01F884B9-021D-42A6-A3B0-A3BFD1A42362Q63582438-E626EE04-E847-4C12-9ECA-17E7EEC4CB96Q63597110-E5FBFE91-C4C3-4991-9465-27109C9363D6Q86246248-E65F2841-849B-4E86-A704-67F6F01EBC2AQ86248070-69DC2719-5C86-477A-8015-E8D4FC5124A5Q86280141-0EFB14D9-698A-4F4D-BB33-2EB9F2F7C4B0Q93214857-2A866116-87B4-484E-8F2B-5F83D221EA55Q93328944-05EBB1B0-A197-49D5-BA19-B8661AEB91CD
P4844
description
Arzneistoff
@de
chemesch Verbindung
@lb
chemical compound
@en
chemical compound
@en-ca
chemical compound
@en-gb
chemická sloučenina
@cs
chemická zlúčenina
@sk
chemiese verbinding
@af
chemische Verbindung
@de-ch
chemische verbinding
@nl
name
Artesunaatti
@fi
Artesunat
@de
Artesunat
@ro
Artesunat
@sh
Artesunat
@sr
Artesunate
@vi
artesunat
@nn
artesunate
@en
artesunato
@es
artesunato
@pt
type
label
Artesunaatti
@fi
Artesunat
@de
Artesunat
@ro
Artesunat
@sh
Artesunat
@sr
Artesunate
@vi
artesunat
@nn
artesunate
@en
artesunato
@es
artesunato
@pt
altLabel
(3R,5aS,6R,8aS,9R,10S,12R,12aR ...... xepin-10-ol hydrogen succinate
@en
AS
@en
Arsumax
@en
Artesunate
@en
artesunato
@en
artesunatum
@en
artesunic acid
@en
butanedioic acid, 1-[(3R,5aS,6 ...... 1,2-benzodioxepin-10-yl] ester
@en
dihydroqinghasu hemsuccinate
@en
prefLabel
Artesunaatti
@fi
Artesunat
@de
Artesunat
@ro
Artesunat
@sh
Artesunat
@sr
Artesunate
@vi
artesunat
@nn
artesunate
@en
artesunato
@es
artesunato
@pt